Fundsmith
ADMA · Medicine & biotech

ADMA Biologics

Makes medicines from donated blood plasma to help fight infections.
No change
Fundsmith owns 1.6 million shares of ADMA Biologics, worth about $14 million. That’s less than $1 of every $100 they have in stocks. They didn’t really buy or sell any between April and June.
Mar 31
1,649,493
Jun 30
1,649,493

The numbers

Shares they own
1,649,493
Value on Jun 30, 2026
$13,806,256
about $14 million
Share of their money
0.1%
less than $1 of every $100 · 39th of 41
Price per share on Jun 30
$8.37
Kind
Shares
More about ADMA Biologics
The value uses the price on Jun 30, 2026. The fund may have paid a different price.
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works